Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)

Name: Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)
License: Public Domain

Regeneron Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hypercholesterolemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 283161
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.